Lily Chu

Lily Chu, MD, MSHS, is board certified in both internal medicine and geriatric medicine.

Education
As per LinkedIn bio:


 * Geriatric Medicine Fellowship, University of California, Los Angeles
 * MSHS, Public Health, University of California, Los Angeles
 * Internal Medicine Residency, University of Rochester
 * MD, University of Washington
 * BS, Biology, University of Washington

Boards and Committees

 * Community Advisory Board Member at Stanford University Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Initiative


 * Co-Vice president of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis


 * Panel member of the 2015 Institute of Medicine report: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness

April 2013 FDA Workshop Survey

 * Preliminary Results – April 2013 FDA Workshop Survey, By Lily Chu, Leonard Jason, Madison Sunnquist, and Suzanna So

Open Letter to The Lancet
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Chu, along with 41 colleagues in the ME/CFS field, signed the second letter.
 * 10 February 2016, An open letter to The Lancet, again - Virology blog

ME/CFS Common Data Element (CDE) Project
Co-chair of Post-Exertional Malaise Working Group and a member of the Sleep Working Group and the Biomarkers Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.

Quotes

 * 2016, "Ultimately the best way to prevent suicide in ME/CFS will be to find effective disease-modifying treatments or cures for it."

Publications

 * 2012, "Exercise and chronic fatigue syndrome: maximize function, minimize post-exertional malaise," Letter to the Editor, European Journal of Clinical Investigation
 * May 2016, Suicide and ME/CFS -- Lily Chu, MD, MSHS
 * 2017, Article commentary - Differences of opinion on systemic exercise intolerance disease are not ‘mistakes’: a rejoinder to Jason Sunnquist, Gleason and Fox

Notable Studies

 * 2013, Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology (Full Text)
 * 2017, Cytokine signature associated with disease severity in chronic fatigue syndrome patients (Full Text)
 * 2017, Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria
 * 2018, Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey (Full Text)
 * 2019, Onset patterns and course of myalgic encephalomyelitis/ chronic fatigue syndrome

Talks and Interviews

 * 2015, Solve CFS Webinar - Post-Exertional Malaise: History, Characteristics, Evidence
 * Written questions and answers to Dr. Chu's webinar

HHS/CFSAC Testimony

 * CFSAC Public Testimony December 2014
 * Written Testimony for June 2012 meeting
 * Written Testimony for Nov 2011 meeting
 * Written Testimony for May 2011 meeting
 * Written Testimony for October 2009 meeting

Online Presence

 * LinkedIn